Cargando…

Gastrointestinal and liver involvement in patients with COVID-19

Detalles Bibliográficos
Autores principales:	Barrera, Francisco J, González-González, José G, Rodríguez-Gutiérrez, René
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7431155/ https://www.ncbi.nlm.nih.gov/pubmed/32818458 http://dx.doi.org/10.1016/S2468-1253(20)30209-0

Ejemplares similares

Gastrointestinal and liver involvement in patients with COVID-19
por: Xu, Yongxing, et al.
Publicado: (2020)

Gastrointestinal and liver involvement in patients with COVID-19 – Authors' reply
por: Qiu, Yun, et al.
Publicado: (2020)

The safety of BCG revaccination in the context of COVID-19
por: Sánchez-García, Adriana, et al.
Publicado: (2023)

Liver and Gastrointestinal Involvement in Patients With COVID-19: A Retrospective Study
por: Aljaroudi, Mahdi E, et al.
Publicado: (2022)

Gastrointestinal Involvement in Dermatomyositis
por: Matas-Garcia, Ana, et al.
Publicado: (2022)

Gastrointestinal and Liver Manifestations of COVID-19
por: Agarwal, Amol, et al.
Publicado: (2020)

Manifestations and prognosis of gastrointestinal and liver involvement in patients with COVID-19: a systematic review and meta-analysis
por: Mao, Ren, et al.
Publicado: (2020)

Gastrointestinal and liver manifestations in patients with COVID-19
por: Lee, I-Cheng, et al.
Publicado: (2020)

Gastrointestinal Kaposi’s sarcoma involving stomach, duodenum, and colon
por: Gonzalez-Moreno, Emmanuel I., et al.
Publicado: (2015)

Gastrointestinal and liver manifestations of COVID-19
por: Cheong, Janice, et al.
Publicado: (2020)

Inflammatory effect on the gastrointestinal system associated with COVID-19
por: Delgado-Gonzalez, Paulina, et al.
Publicado: (2021)

Gastrointestinal and Liver Manifestations in COVID-19 Population
por: Saleem, Saad, et al.
Publicado: (2021)

Somatostatin analog therapy effectiveness on the progression of polycystic kidney and liver disease: A systematic review and meta-analysis of randomized clinical trials
por: Suwabe, Tatsuya, et al.
Publicado: (2021)

Gastrointestinal System Involvement in COVID
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

Prevalence of Diabetes and Hypertension and Their Associated Risks for Poor Outcomes in Covid-19 Patients
por: Barrera, Francisco J, et al.
Publicado: (2020)

COVID-19: Gastrointestinal manifestations, liver injury and recommendations
por: Ozkurt, Zulal, et al.
Publicado: (2022)

SUN-325 A Neuroendocrine Tumor with Liver Metastases in a patient with Acid Peptic Disease
por: López Maldonado, Francisco, et al.
Publicado: (2019)

Gastrointestinal involvement in COVID-19: a systematic review and meta-analysis
por: Rokkas, Theodore
Publicado: (2020)

Gastrointestinal Basidiobolomycosis Accompanied by Liver Involvement: A Case Report
por: Ejtehadi, Fardad, et al.
Publicado: (2014)

Neuromuscular involvement in COVID-19 critically ill patients
por: Cabañes-Martínez, Lidia, et al.
Publicado: (2020)

COVID-19 and gastrointestinal tract()
por: Sebastián Domingo, Juan José
Publicado: (2020)

Gastrointestinal involvement in COVID-19 patients: a retrospective study from a Greek COVID-19 referral hospital
por: Tsibouris, Panagiotis, et al.
Publicado: (2020)

COVID-19 status quo: Emphasis on gastrointestinal and liver manifestations
por: Bhurwal, Abhishek, et al.
Publicado: (2021)

COVID-19 in liver transplant patients: Impact and considerations
por: Khazaaleh, Shrouq, et al.
Publicado: (2023)

Biomodulina T (InmunyVital(®)) Restores T Cells and Helps Contain COVID-19
por: Rodriguez Martin, Roman R., et al.
Publicado: (2020)

Liver injury with COVID-19 based on gastrointestinal symptoms and pneumonia severity
por: Kaneko, Shun, et al.
Publicado: (2020)

Gastrointestinal and Liver Manifestations in Children with COVID-19 and Their Relationship to Clinical Course
por: Alkan, Gülsüm, et al.
Publicado: (2022)

The early stage of COVID-19 pandemic: Gastrointestinal manifestations and liver injury in COVID-19 patients in Wuhan, China
por: Chen, Dafan, et al.
Publicado: (2022)

Trustworthiness of randomized trials in endocrinology—A systematic survey
por: González-González, José Gerardo, et al.
Publicado: (2019)

Effect of online hemodiafiltration compared with hemodialysis on quality of life in patients with ESRD: A systematic review and meta-analysis of randomized trials
por: Suwabe, Tatsuya, et al.
Publicado: (2018)

Longitudinal relationship of liver injury with inflammation biomarkers in COVID-19 hospitalized patients using a joint modeling approach
por: Diaz-Louzao, Carla, et al.
Publicado: (2022)

STORE-gastrointestinal functions and gastrointestinal hormones in patients with liver failure
por: Wang, Ping, et al.
Publicado: (2018)

Involvement of the Liver in COVID-19: A Systematic Review
por: Kariyawasam, Jayani C., et al.
Publicado: (2022)

Reply to: “Liver fibrosis and adverse outcomes in COVID-19”
por: Ruiz-Margáin, Astrid, et al.
Publicado: (2021)

COVID-19-associated gastrointestinal and liver injury: clinical features and potential mechanisms
por: Zhong, Peijie, et al.
Publicado: (2020)

Is liver involvement overestimated in COVID-19 patients? A meta-analysis
por: Li, Gang, et al.
Publicado: (2021)

Multidrug-Resistant Tuberculosis and Its Association with Adrenal Insufficiency: Assessment with the Low-Dose ACTH Stimulation Test
por: Rodríguez-Gutiérrez, René, et al.
Publicado: (2016)

Gastrointestinal Involvement in Long COVID and Potential Pathogenic Mechanisms
por: Jadali, Zohreh, et al.
Publicado: (2022)

Gastrointestinal involvement of COVID-19 and potential faecal transmission of SARS-CoV-2
por: Song, Min, et al.
Publicado: (2020)

Anti-tumoral activity of single and combined regorafenib treatments in preclinical models of liver and gastrointestinal cancers
por: Fondevila, Flavia, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_bvsng8crf4bnbd7isuhgtqehhk